SCHEMBL29516232

SCHEMBL29516232

Cc1cc(C)cc(-c2nc(NS(=O)(=O)c3ccccc3)nc3ccccc23)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.56
SMN1; SMN2 Q16637 3/20 0.48
GAA P10253 3/20 0.48
PKM P14618 1/20 0.48
FFAR4 Q5NUL3 1/20 0.48
NUDT1 P36639 1/20 0.47
MEN1 O00255 4/20 0.46
KMT2A Q03164 4/20 0.46
KDM4E B2RXH2 3/20 0.46
LMNA P02545 3/20 0.46
HTT P42858 2/20 0.46
TDP1 Q9NUW8 2/20 0.46
MAPT P10636 2/20 0.46
ALDH1A1 P00352 3/20 0.46
CNR1 P21554 1/20 0.46
GPR55 Q9Y2T6 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
POLB P06746 1/20 0.45
CYP3A4 P08684 1/20 0.44
SLC40A1 Q9NP59 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24287750 1.00 TSHR (0.56) TSHRSMN1; SMN2GAAPKMFFAR4
SCHEMBL24287513 0.80 TSHR (0.48) TSHRSMN1; SMN2GAAPKMFFAR4
SCHEMBL29516231 0.80 TSHR (0.48) TSHRSMN1; SMN2GAAPKMFFAR4
SCHEMBL29516442 0.80 KDM4E (0.48) TSHRGAAPKMFFAR4KDM4E
SCHEMBL24287719 0.80 KDM4E (0.48) TSHRGAAPKMFFAR4KDM4E
SCHEMBL24287288 0.77 KDM4E (0.50) TSHRGAAPKMFFAR4KDM4E
SCHEMBL29516427 0.77 KDM4E (0.50) TSHRGAAPKMFFAR4KDM4E
SCHEMBL26810905 0.74 SMN1; SMN2 (0.54) TSHRSMN1; SMN2GAAPKMFFAR4
SCHEMBL26797294 0.74 FFAR4 (0.54) TSHRGAAPKMFFAR4KDM4E
SCHEMBL24287271 0.74 KDM4E (0.59) TSHRSMN1; SMN2GAAPKMMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225750-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 EP disclosed
WO-2022076629-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 WO disclosed